Carregant...
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women
Objective: To investigate the efficacy, safety, and dose response of three doses of ibandronate, given intermittently by intravenous (IV) injection every three months, in preventing postmenopausal osteoporosis. Patients and methods: 629 postmenopausal women, categorised according to time since menop...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2003
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1754320/ https://ncbi.nlm.nih.gov/pubmed/12972476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.62.10.969 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|